Kenvue Inc. reported a net income of $474 million for the fiscal three months ended March 29, 2026, a significant increase of 47.2% compared to $322 million in the same period last year. The company's revenue also saw a rise, with net sales reaching $3.909 billion, up 4.5% from $3.741 billion in the previous fiscal period. This growth was attributed to favorable pricing actions and a slight increase in organic sales, despite a decrease in volume related to lower incidences of illnesses affecting key product categories.
The company's cost of sales remained relatively stable at $1.607 billion, reflecting a modest increase of 2.2% year-over-year. Gross profit margin improved to 58.9%, up from 58.0%, driven by supply chain optimization initiatives. Selling, general, and administrative expenses decreased by 5.5% to $1.453 billion, primarily due to savings from restructuring initiatives and a reduction in separation-related costs. Kenvue's operating income rose to $767 million, a 37.5% increase from $558 million in the prior year.
In terms of strategic developments, Kenvue is in the process of merging with Kimberly-Clark Corporation, with shareholders approving the merger agreement in January 2026. The transaction, expected to close in the second half of 2026, will see Kenvue shareholders receive a combination of Kimberly-Clark stock and cash. Additionally, Kenvue has initiated a 2026 Restructuring Initiative aimed at optimizing its operating model and reducing complexity, which is projected to incur approximately $250 million in pre-tax restructuring expenses.
Operationally, Kenvue's three business segments—Self Care, Skin Health and Beauty, and Essential Health—reported varied performance. The Self Care segment generated $1.699 billion in sales, a slight increase, while Skin Health and Beauty saw an 8.4% rise to $1.059 billion. The Essential Health segment also grew by 4.9% to $1.151 billion. The company continues to focus on product innovation and geographic expansion, particularly in North America and Latin America, to drive future growth.
Looking ahead, Kenvue anticipates ongoing challenges from macroeconomic conditions, including inflation and supply chain disruptions, particularly due to geopolitical tensions and tariffs. However, the company remains optimistic about its ability to generate positive cash flows and meet its financial obligations, supported by a strong liquidity position with cash and cash equivalents of $1.075 billion as of March 29, 2026.
About Kenvue Inc.
Kenvue is a global consumer health company specializing in trusted brands across self-care, skin health, beauty, and essential health categories. It offers over-the-counter medicines, personal care, and dermatological products to consumers worldwide. Leveraging science, innovation, and digital marketing, it focuses on everyday care, brand differentiation, and sustainable growth in diverse markets. Its business model emphasizes brand strength, consumer insights, and global supply chain resilience.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.